Loading clinical trials...
Loading clinical trials...
Pediatric Blood & Marrow Transplant Consortium (PBMTC) Phase II Myeloablative Haploidentical BMT With Post-transplantation Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Conditions
Interventions
Cyclophosphamide
TBI
+4 more
Locations
9
United States
Children's Hospital of Colorado
Aurora, Colorado, United States
Nemours Alfred I. DuPont Hospital for Children
Wilmington, Delaware, United States
All Children's Hospital Johns Hopkins Medicine
St. Petersburg, Florida, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Washington University in St. Louis
St Louis, Missouri, United States
Levine Cancer Center
Charlotte, North Carolina, United States
Start Date
July 2, 2015
Primary Completion Date
June 15, 2018
Completion Date
October 1, 2020
Last Updated
November 26, 2021
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions